{"status": "ok", "totalResults": 1, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": "Reuters", "title": "EU delays approval of Novavax's revised COVID vaccine - Reuters", "description": "European Union (EU) regulators have delayed a decision to give approval for Novavax's <a href=\"https://www.reuters.com/markets/companies/NVAX.O\" target=\"_blank\">(NVAX.O)</a> variant-tailored COVID-19 vaccine, the company said on Sunday.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/eu-delays-approval-novavaxs-revised-covid-vaccine-ft-2023-10-15/", "urlToImage": "https://www.reuters.com/resizer/px0egVMlVYxPh2uuP5yXjQ4wc2Q=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/GHTDDZVPHVNBDFXQD27Y5KPIAY.jpg", "publishedAt": "2023-10-15T16:36:00Z", "content": "Oct 15 (Reuters) - European Union (EU) regulators have delayed a decision to give approval for Novavax's (NVAX.O) variant-tailored COVID-19 vaccine, the company said on Sunday.\r\nThe European Medicine\u2026 [+1386 chars]"}]}